(Q34017229)

30 July 2017

1 reference

title

Statistical analysis, trial design and duration in Alzheimer's disease clinical trials: a review (English)

1 reference

30 July 2017

0 references

0 references

P A Thompson

1

1 reference

30 July 2017

D E Wright

series ordinal

2

1 reference

30 July 2017

C E Counsell

series ordinal

3

1 reference

30 July 2017

J Zajicek

series ordinal

4

1 reference

30 July 2017

13 September 2011

1 reference

International Psychogeriatrics

30 July 2017

1 reference

30 July 2017

24

1 reference

30 July 2017

5

1 reference

30 July 2017

689-697

1 reference

Cognitive assessment in the elderly: a review of clinical methods

30 July 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211001116

Advances in the early detection of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211001116

Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211001116

Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211001116

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211001116

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211001116

Correlation between rates of brain atrophy and cognitive decline in AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211001116

Revising the definition of Alzheimer's disease: a new lexicon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211001116

Biomarkers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211001116

3D mapping of mini-mental state examination performance in clinical and preclinical Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211001116

The analysis of multiple endpoints in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211001116

7 January 2021

Some statistical methods for multiple endpoints in clinical trials

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211001116

7 January 2021

On the design and analysis of randomized clinical trials with multiple endpoints

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211001116

7 January 2021

Modelling mini mental state examination changes in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211001116

7 January 2021

10.1017/S1041610211001116

Identifiers

DOI

1 reference

30 July 2017

1 reference